Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.7B | 3.5B | 3.9B | 4.1B |
Cost of revenue | 3.5B | 3.3B | 3.4B | 3.6B |
Gross profit | 234M | 191M | 405M | 489M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 120M | 107M | 104M | 105M |
Other operating expenses | -10M | 15M | 30M | 19M |
Operating income | -125M | -182M | 36M | 148M |
Non operating interest income | ||||
Income | 10M | 16M | 23M | 25M |
Expense | 45M | 15M | 5M | 2M |
Other income expense | 14M | 70M | 54M | 73M |
Pretax income | -147M | -119M | 109M | 239M |
Tax provision | -31M | -30M | -10M | 56M |
Net income | -116M | -89M | 119M | 183M |
Basic EPS | — | -0.4 | 0.5 | 0.8 |
Diluted EPS | — | -0.4 | 0.5 | 0.7 |
Basic average shares | — | 225.2M | 225.1M | 224.9M |
Diluted average shares | — | 225.2M | 254.1M | 254.2M |
EBITDA | 140M | 146M | 345M | 463M |
Net income from continuing op. | -116M | -89M | 119M | 183M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |